Alkaline phosphatase activity after cardiothoracic surgery in infants and correlation with post-operative support and inflammation: a prospective cohort study
- PMID: 22906145
- PMCID: PMC3580750
- DOI: 10.1186/cc11483
Alkaline phosphatase activity after cardiothoracic surgery in infants and correlation with post-operative support and inflammation: a prospective cohort study
Abstract
Introduction: Limited evidence suggests that serum alkaline phosphatase activity may decrease after cardiac surgery in adults and children. The importance of this finding is not known. Recent studies, however, have identified a potential role for alkaline phosphatase as modulator of inflammation in multiple settings, including during adult cardiopulmonary bypass. We sought to describe the change in alkaline phosphatase activity after cardiothoracic surgery in infants and to assess for a correlation with intensity and duration of post-operative support, markers of inflammation, and short-term clinical outcomes.
Methods: Sub-analysis of a prospective observational study on the kinetics of procalcitonin in 70 infants (≤ 90 days old) undergoing cardiothoracic surgery. Subjects were grouped based on the use of cardiopulmonary bypass and delayed sternal closure. Alkaline phosphatase, procalcitonin, and C-reactive protein (CRP) levels were obtained pre-operation and on post-operative day 1. Mean change in alkaline phosphatase activity was determined in each surgical group. Generalized linear modeling and logistic regression were employed to assess for associations between post-operative alkaline phosphatase activity and post-operative support, inflammation, and short term outcomes. Primary endpoints were vasoactive-inotropic score at 24 hours and length of intubation. Secondary endpoints included procalcitonin/CRP levels on post-operative day 1, length of hospital stay, and cardiac arrest or death.
Results: Mean decrease in alkaline phosphatase was 30 U/L (p = 0.01) in the non-bypass group, 114 U/L (p < 0.0001) in the bypass group, and 94 U/L (p < 0.0001) in the delayed sternal closure group. On multivariate analysis, each 10 U/L decrease in alkaline phosphatase activity on post-operative day 1 was independently associated with an increase in vasoactive-inotropic score by 0.7 (p < 0.0001), intubation time by 6% (p < 0.05), hospital stay by 5% (p < 0.05), and procalcitonin by 14% (P < 0.01), with a trend towards increased odds of cardiac arrest or death (OR 1.3; p = 0.06). Post-operative alkaline phosphatase activity was not associated with CRP (p = 0.7).
Conclusions: Alkaline phosphatase activity decreases after cardiothoracic surgery in infants. Low post-operative alkaline phosphatase activity is independently associated with increased procalcitonin, increased vasoactive/inotropic support, prolonged intubation time, and prolonged hospital stay. Alkaline phosphatase may serve as a biomarker and potential modulator of post-operative support and inflammation following cardiothoracic surgery in infants.
Figures
Similar articles
-
Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.Metab Brain Dis. 2019 Feb;34(1):3-19. doi: 10.1007/s11011-018-0322-3. Epub 2018 Oct 4. Metab Brain Dis. 2019. PMID: 30284677 Free PMC article. Review.
-
Kinetics of procalcitonin and C-reactive protein and the relationship to postoperative infection in young infants undergoing cardiovascular surgery.Pediatr Res. 2013 Oct;74(4):413-9. doi: 10.1038/pr.2013.124. Epub 2013 Jul 17. Pediatr Res. 2013. PMID: 23863853 Free PMC article.
-
Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery.Intensive Care Med. 2012 Jul;38(7):1184-90. doi: 10.1007/s00134-012-2544-x. Epub 2012 Apr 14. Intensive Care Med. 2012. PMID: 22527067 Free PMC article.
-
Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries.Pediatr Crit Care Med. 2014 Jul;15(6):529-37. doi: 10.1097/PCC.0000000000000153. Pediatr Crit Care Med. 2014. PMID: 24777300 Free PMC article.
-
An evidence-based review of the use of vasoactive and inotropic medications in post-operative paediatric patients after cardiac surgery with cardiopulmonary bypass from 2000 to 2020.Cardiol Young. 2020 Dec;30(12):1757-1771. doi: 10.1017/S1047951120004151. Epub 2020 Nov 20. Cardiol Young. 2020. PMID: 33213604
Cited by
-
Impact of Venoarterial Extracorporeal Membrane Oxygenation on Alkaline Phosphatase Metabolism after Cardiac Surgery.Biomolecules. 2021 May 17;11(5):748. doi: 10.3390/biom11050748. Biomolecules. 2021. PMID: 34067880 Free PMC article.
-
Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.Metab Brain Dis. 2019 Feb;34(1):3-19. doi: 10.1007/s11011-018-0322-3. Epub 2018 Oct 4. Metab Brain Dis. 2019. PMID: 30284677 Free PMC article. Review.
-
Impact of Subclinical Congestion on Outcome of Patients Undergoing Mitral Valve Surgery.Biomedicines. 2020 Sep 19;8(9):363. doi: 10.3390/biomedicines8090363. Biomedicines. 2020. PMID: 32961736 Free PMC article.
-
Change in alkaline phosphatase activity associated with intensive care unit and hospital length of stay in patients with septic acute kidney injury on continuous renal replacement therapy.BMC Nephrol. 2018 Sep 20;19(1):243. doi: 10.1186/s12882-018-1028-9. BMC Nephrol. 2018. PMID: 30236070 Free PMC article.
-
"Calcium-Phosphorus-Magnesium Axis" and the Metabolic Issue of Newborns Undergoing Parenteral Nutrition: Is It Time to Change Our Perspectives?Nutrients. 2025 Feb 23;17(5):775. doi: 10.3390/nu17050775. Nutrients. 2025. PMID: 40077645 Free PMC article.
References
-
- Magnusson P, Larsson L, Englund G, Larsson B, Strang P, Selin-Sjogren L. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clinical ChemistryI. 1998;44:1621–1628. - PubMed
-
- Crofton PM, Hume R. Alkaline phosphatase isoenzymes in the plasma of preterm and term infants: serial measurements and clinical correlations. Clin Chem. 1987;33:1783–1787. - PubMed
-
- Chen KT, Malo MS, Moss AK, Zeller S, Johnson P, Ebrahimi F, Mostafa G, Alam SN, Ramasamy S, Warren HS, Hohmann EL, Hodin RA. Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am J Physiol Gastrointest Liver Physiol. 2010;299:G467–475. doi: 10.1152/ajpgi.00364.2009. - DOI - PMC - PubMed
-
- Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, Bowers BE, Scully M, Bruyninckx WJ, Colgan SP. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci USA. 2010;107:14298–14303. doi: 10.1073/pnas.0914730107. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous